Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose S Pulido

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
Retina (Philadelphia, Pa.)|January 25, 2012
The teacher's teacherJose S Pulido
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 15, 2006
Heart outcomes prevention evaluation-the ongoing outcomes study, vitamin E, and age-related macular degenerationJose S Pulido
Transactions of the American Ophthalmological Society|January 28, 2003
Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysisJose S Pulido,
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 15, 2010
Monitoring systemic complications of intraocular medicationsJose S Pulido
Retina (Philadelphia, Pa.)|February 10, 2009
Rituximab for intraocular lymphomaSujit Itty, Jose S Pulido
Journal of Clinical Apheresis|August 18, 2005
Rheopheresis for macular degeneration: the data is not there yet to justify itJose S Pulido, Jeffrey Winters
Ocular Immunology and Inflammation|October 10, 2013
False-positive anti-retinal antibodies as a cause of psychogenic vision lossYi Cai, Jose S Pulido
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|May 31, 2017
Posterior Pole and Peripheral Retinal Fibrovascular Proliferation in von Hippel Lindau DiseaseEbrahim Elborgy, Jose S Pulido
The British Journal of Ophthalmology|March 27, 2009
Systemic antiangiogenic therapy: what goes aroundJose S Pulido, Sujit Itty
Retina (Philadelphia, Pa.)|May 15, 2020
The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal LymphomaAndrew W Stacey, Jose S Pulido
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
Retina (Philadelphia, Pa.)|January 25, 2012
The teacher's teacherJose S Pulido
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 15, 2006
Heart outcomes prevention evaluation-the ongoing outcomes study, vitamin E, and age-related macular degenerationJose S Pulido
Transactions of the American Ophthalmological Society|January 28, 2003
Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysisJose S Pulido,
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 15, 2010
Monitoring systemic complications of intraocular medicationsJose S Pulido
Retina (Philadelphia, Pa.)|February 10, 2009
Rituximab for intraocular lymphomaSujit Itty, Jose S Pulido
Journal of Clinical Apheresis|August 18, 2005
Rheopheresis for macular degeneration: the data is not there yet to justify itJose S Pulido, Jeffrey Winters
Ocular Immunology and Inflammation|October 10, 2013
False-positive anti-retinal antibodies as a cause of psychogenic vision lossYi Cai, Jose S Pulido
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|May 31, 2017
Posterior Pole and Peripheral Retinal Fibrovascular Proliferation in von Hippel Lindau DiseaseEbrahim Elborgy, Jose S Pulido
The British Journal of Ophthalmology|March 27, 2009
Systemic antiangiogenic therapy: what goes aroundJose S Pulido, Sujit Itty
Retina (Philadelphia, Pa.)|May 15, 2020
The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal LymphomaAndrew W Stacey, Jose S Pulido
Pageof 32